Title: A Novel Inflammatory Biomarker in Assessing Disease Activity in Ulcerative Colitis:
Gasdermin D
Version: 3 Date: 19 May 2025
Reviewer's report:
Dear Author,
I read the manuscript entitled “A Novel Inflammatory Biomarker in Assessing Disease Activity
in Ulcerative Colitis: Gasdermin D”.  I have some comments and suggestions for the paper:
“Table 2” section:
a) It is not understood why there is the word " SD: Standart deviation" under Table 2. It is
appropriate to delete it.
Title: A Novel Inflammatory Biomarker in Assessing Disease Activity in Ulcerative Colitis:
Gasdermin D
Version: 3 Date: 19 May 2025
Reviewer's report:
Dear Author,
I read the manuscript entitled “A Novel Inflammatory Biomarker in Assessing Disease Activity
in Ulcerative Colitis: Gasdermin D”.  I have some comments and suggestions for the paper:
“Table 2” section:
a) It is not understood why there is the word " SD: Standart deviation" under Table 2. It is
appropriate to delete it.
Please review this paper.
user
Title: A Novel Inflammatory Biomarker in Assessing Disease Activity in Ulcerative Colitis:
Gasdermin D
Version: 3 Date: 19 May 2025
Reviewer's report:
Dear Author,
I read the manuscript entitled “A Novel Inflammatory Biomarker in Assessing Disease Activity
in Ulcerative Colitis: Gasdermin D”.  I have some comments and suggestions for the paper:
“Table 2” section:
a) It is not understood why there is the word " SD: Standart deviation" under Table 2. It is
appropriate to delete it.
assistant